BETA DRUGS
Back to Income Statement
|
BETA DRUGS Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹288 Cr | ₹236 Cr | ₹174 Cr | ₹141 Cr | ₹91 Cr |
What is the latest Total Expenditure of BETA DRUGS ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹288 Cr |
| Mar2024 | ₹236 Cr |
| Mar2023 | ₹174 Cr |
| Mar2022 | ₹141 Cr |
| Mar2021 | ₹91 Cr |
How is Total Expenditure of BETA DRUGS Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹288 Cr | 22.08 | |
| Mar2024 | ₹236 Cr | 35.48 | |
| Mar2023 | ₹174 Cr | 23.27 | |
| Mar2022 | ₹141 Cr | 54.46 | |
| Mar2021 | ₹91 Cr | - | |
Compare Total Expenditure of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹1,862.2 Cr | -15.8% | -19.6% | 6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -0.8% | -5.1% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -3.2% | -1.4% | 53.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -1.6% | -6% | 32.1% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | 0% | -3.6% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 3.1% | 8.7% | -1.5% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -15.8% |
-19.6% |
6% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses